Work

The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer.

Year: 2000

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: W K Kelly, I Osman, V E Reuter, T Curley, W D Heston, D M Nanus, H I Scher

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

Awards: PAPILLOMA VIRUS ACTIONS ON HOST CELL GENE PRODUCTS, CANCER CHEMOTHERAPY PROGRAM PROJECT

OpenAlex ID: W1527656746

FWCI: 6.291

Cites: 17

Cited by: 57

Related to: 10